BioMarin Pharmaceutical Inc. moved Aryplase (galsulfase) into the FDA's hands, filing for approval of the enzyme-replacement therapy for the treatment of mucopolysaccharidosis VI (MPS VI), an inherited and life-threatening disease for which no drug therapies are available. (BioWorld Today)

Cubist Pharmaceuticals Inc. raised more than $100 million through a larger public offering of its common shares than originally expected. (BioWorld Today)

Cubist Pharmaceuticals Inc. raised more than $100 million through a larger public offering of its common shares than originally expected. (BioWorld Today)

The FDA approved a new lung cancer drug, Tarceva (erlotinib), but a surprise in the agency's authorization might have driven down share values in the companies that developed it - OSI Pharmaceuticals Inc. and Genentech Inc. (BioWorld Today)

The FDA approved a new lung cancer drug, Tarceva (erlotinib), but a surprise in the agency's authorization might have driven down share values in the companies that developed it - OSI Pharmaceuticals Inc. and Genentech Inc. (BioWorld Today)